Cost Analysis and Rationale for Universal Pharmacare in Canada

Exploring the estimated annual cost of implementing universal pharmacare in Canada, projected at 30 to 40 billion but potentially reduced to 13 or 14 billion when considering existing public drug programs. The chapter emphasizes the importance of investing in pharmacare to alleviate strain on the healthcare system by addressing untreated conditions like diabetes.